✦ LIBER ✦

HER2 status in non-small cell lung cancer (NSCLC): results from the patient screening for enrolment to a phase 2 study of herceptin

✍ Scribed by P. Heinmoeller; C. Gross; C. Schmidtgen; K. Beyser; C. Nordhoff; A. Bockholt; M. Pedrocchi; J. Rueschoff

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomised phase II study of gemcitabi

✍ U. Gatzemeier; G. Groth; V. Hirsh; C. Butts; N. Van Zandwijk; F. Shepherd; R. Ro 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Cisplatin and gemcitabine combined with

✍ R. Zinner; B. Glisson; K. Pisters; F. Khuri; Y. Oh; J. Ro; N. Ordonez; A. El-Nag 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 140 KB

397 Phase 2 results of XL184 in a cohort

✍ C. Yasenchak; K. Nackaerts; A. Awada; S.M. Gadgeel; B. Hellerstedt; M.C. Perry; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Results of a Phase II Trial of Gemcitabi

✍ Marcus A. Neubauer; Craig H. Reynolds; Marcos G. Joppert; Thomas Whittaker; Habi 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 143 KB

Gemcitabine monotherapy in the elderly p

✍ Antonuzzo, A; Galli, L; Ricci, S; Tibaldi, C; Bertuccelli, M; Petruzzelli, S; Ta 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Results of platinum-based chemotherapy i

✍ Stéphane Jouveshomme, Florence Canoui-Poitrine, Aurélie Le Thuaut… 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 282 KB